Cerity Partners’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$331K Sell
5,983
-1,128
-16% -$53.7K ﹤0.01% 2543
2025
Q4
$266K Buy
7,111
+66
+0.9% +$2.68K ﹤0.01% 2475
2025
Q3
$285K Buy
+7,045
New +$233K ﹤0.01% 2313
2024
Q4
Sell
-13,662
Closed -$308K 2548
2024
Q3
$308K Buy
+13,662
New +$264K ﹤0.01% 2046
2024
Q2
Sell
-11,094
Closed -$143K 2355
2024
Q1
$143K Buy
+11,094
New +$133K ﹤0.01% 2165

Other funds holding PAHC

Cerity Partners's PAHC Position: Q1 2026 in Review

Cerity Partners reduced its Phibro Animal Health (PAHC) stake by 16% in Q1 2026, selling an estimated $53.7K and leaving 5,983 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #2543.

Cerity Partners first reported a position in PAHC in Q1 2024 and has held it in 5 quarters since. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Cerity Partners held 5,983 shares of Phibro Animal Health worth $331K as of Q1 2026.
  • Cerity Partners sold 1,128 Phibro Animal Health shares in Q1 2026, an estimated $53.7K.
  • Phibro Animal Health made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #2543 holding.
  • Cerity Partners first reported a position in Phibro Animal Health in Q1 2024 and has held it in 5 quarters since.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.